论文部分内容阅读
[目的]观察阿德福韦酯(ADV)联合培脾舒肝汤治疗慢性乙型肝炎(CHB)的临床疗效。[方法]将60例CHB患者随机分为2组,对照组30例单纯服用阿德福韦酯片。治疗组30例在服用阿德福韦酯片的基础上加服培脾舒肝汤汤剂。[结果]治疗组患者治疗后丙氨酸氨基转移酶和乙肝病毒标志物指标有明显改善,近期及远期疗效都明显优于对照组(P<0.01)。[结论]阿德福韦酯联合培脾舒肝汤治疗CHB可以提高疗效,且疗效稳定。
[Objective] To observe the clinical efficacy of adefovir dipivoxil (ADV) combined with Peipi Shugan Decoction in treating chronic hepatitis B (CHB). [Method] Sixty CHB patients were randomly divided into two groups. The control group received adefovir dipivoxil alone. Treatment group, 30 cases of taking adefovir dipivoxil tablets on the basis of clothing plus spleen and liver soup decoction. [Results] The indexes of alanine aminotransferase and hepatitis B virus markers in the treatment group were significantly improved after treatment, and the short-term and long-term effects were significantly better than those in the control group (P <0.01). [Conclusion] Adefovir Dipivoxil combined with Peipi Shugan Decoction can improve the curative effect and the curative effect is stable.